ADCT: Adc Therapeutics SA Company Profile & Statistics

About

ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.

Info & Links

CEO

Ameet Mallik

Headquarters

BIOPOLE,ROUTE DE LA CORNICHE 3B
EPALINGES, V8 1066, SWITZERLAND

Auditor

PricewaterhouseCoopers SA

Share holders

Employees

274

Adc Therapeutics SA Statistics

Valuation Measures

Market Capitalization²

196.28M

Enterprise Value

36.20M

Enterprise Value/EBITDA(ttm)

-0.27

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.58

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

91.81%

Operating Margin(ttm)

-300.00%

Profit Margin(ttm)

-303.16%

Return on Equity(ttm)

Return on Invested Capital(ttm)

575.97%

Return on Assets(ttm)

-61.33%

Income Statement

Revenue(ttm)

70.72M

Revenue Per Share(ttm)

0.73

Gross Profit(ttm)

64.92M

EBITDA(ttm)³

-134.87M

Net Income Available to Common(ttm)

-212.15M

Diluted EPS(ttm)

-2.39

Share Statistics

Beta (5Y Monthly)

1.52

52-Week Change

82.88%

S&P 500 52-Week Change

27.85%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

96.69M

Dividend Yield

0.00%

Float⁴

92.73M

% Held by Insiders

4.10%

% Held by Institutions

41.10%

Balance Sheet

Total Cash(mrq)

274.27M

Total Cash Per Share(mrq)

2.84

Total Debt(mrq)

114.19M

Total Debt/Equity(mrq)

-66.41%

Current Ratio(mrq)

4.92%

Quick Ratio(mrq)

4.68%

Book Value Per Share(mrq)

-1.78

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.97

Free Cash Flow(ytd)

-102.76M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

ADCT

Adc Therapeutics SA

Adc Therapeutics SA Profile